Aria up premarket on buyout rumors


Shares of Aria Pharmaceuticals (ARIA) are up 7% in premarket trading on rumors that Jazz Pharmaceuticals (JAZZ) is mulling a buyout for as much as $20/share versus yesterday's close of $7.60. This would value the acquisition at ~$3.6B.

Consensus 2014 and 2015 revenue estimates for ARIA are $87.9M and $158.4M, respectively.

287 mutual funds own ARIA, down from 505 a year earlier.

From other sites
Comments (5)
  • jjg123
    , contributor
    Comments (2) | Send Message
     
    Buyout or not, its a good company and should be in low teens anyway.
    Thanking AF for the bargain dips.
    28 Mar 2014, 09:44 AM Reply Like
  • ARAMSRI
    , contributor
    Comments (5) | Send Message
     
    JAZZ should merge or buy QCOR
    28 Mar 2014, 09:49 AM Reply Like
  • ebayhacker
    , contributor
    Comments (27) | Send Message
     
    Saw the news, did a little research, and bought 20 $10 JAN15 options on ARIA in my IRA with some of my profits from previous BAC options contracts. Buyout or not, I think I'll be a winner at the end of the year on this one after a little research this morning.
    28 Mar 2014, 12:30 PM Reply Like
  • 2supersheps
    , contributor
    Comment (1) | Send Message
     
    Who's AF?
    30 Mar 2014, 03:09 AM Reply Like
  • soughtalpha2
    , contributor
    Comments (11) | Send Message
     
    Aria is and will be a rollercoaster
    30 Mar 2014, 09:02 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs